Imaging improves diagnosis of dementia with lewy bodies
- PMID: 20140120
- PMCID: PMC2808791
- DOI: 10.4306/pi.2009.6.4.233
Imaging improves diagnosis of dementia with lewy bodies
Abstract
Dementia with Lewy bodies (DLB) is the second most common cause of degenerative dementia after Alzheimer's disease (AD), and is clinically characterized by the progressive cognitive decline with fluctuations in cognition and alertness, recurrent visual hallucinations and Parkinsonism. Once these characteristic symptoms of DLB emerge, discriminating it from AD is relatively easy. However, in the early disease stages, the clinical symptoms of various types of dementias largely overlap and it is difficult to distinguish DLB from other neurodegenerative dementias based on clinical manifestations alone. To increase the accuracy of antemortem diagnosis of DLB, the latest diagnostic criteria incorporate findings from 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy, or from neuroimaging such as computed tomography (CT), magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT), and positron emission tomography (PET). In the present guidelines, decreased dopamine transporter uptake revealed by SPECT or PET receives the greatest importance among various neuroimaging findings and is listed as one of the suggestive features. Supportive features that commonly present but are not proven to have diagnostic specificity include relatively-preserved medial-temporal-lobe structures, occipital hypoperfusion, and abnormal MIBG myocardial scintigraphy. In this paper, we review the major findings on various neuroimaging modalities and discuss the clinical usefulness of them for the diagnosis of DLB. Although there is not enough evidence to reach the conclusion, considering the accessibility in clinical practice, in our personal views, we recommend the use of brain-perfusion SPECT and MIBG myocardial scintigraphy to improve the diagnosis of DLB.
Keywords: 123I-metaiodobenzylguanidine myocardial scintigraphy; Dementia; Dementia with Lewy bodies; Magnetic resonance imaging; Positron emission tomography; Single photon emission computed tomography.
Similar articles
-
The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and 123 I-metaiodobenzylguanidine myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.Psychogeriatrics. 2017 Jul;17(4):247-255. doi: 10.1111/psyg.12227. Epub 2017 Jan 28. Psychogeriatrics. 2017. PMID: 28130808
-
Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features?Br J Radiol. 2017 Feb;90(1070):20160156. doi: 10.1259/bjr.20160156. Epub 2016 Nov 29. Br J Radiol. 2017. PMID: 27897064 Free PMC article.
-
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):184-192. doi: 10.1007/s00259-015-3146-y. Epub 2015 Aug 2. Eur J Nucl Med Mol Imaging. 2016. PMID: 26233438 Free PMC article.
-
Clinical imaging in dementia with Lewy bodies.Evid Based Ment Health. 2018 May;21(2):61-65. doi: 10.1136/eb-2017-102848. Epub 2018 Mar 29. Evid Based Ment Health. 2018. PMID: 29602778 Free PMC article. Review.
-
Dementia with Lewy bodies: diagnosis and management.Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S12-8. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps562>3.0.co;2-3. Int J Geriatr Psychiatry. 2001. PMID: 11748785 Review.
Cited by
-
Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.PLoS One. 2011 Apr 28;6(4):e18569. doi: 10.1371/journal.pone.0018569. PLoS One. 2011. PMID: 21552550 Free PMC article.
-
Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease.Neurology. 2011 May 24;76(21):1797-803. doi: 10.1212/WNL.0b013e31821ccc83. Epub 2011 Apr 27. Neurology. 2011. PMID: 21525427 Free PMC article.
-
THE ENIGMA OF LEWY BODY DEMENTIA: A CASE REPORT.Acta Clin Croat. 2020 Dec;59(4):771-776. doi: 10.20471/acc.2020.59.04.27. Acta Clin Croat. 2020. PMID: 34285451 Free PMC article.
-
Psychogenic Movement Disorders and Dopamine Transporter Scans: Still a Clinical Diagnosis?Psychosomatics. 2017 Jan-Feb;58(1):83-89. doi: 10.1016/j.psym.2016.08.009. Epub 2016 Aug 25. Psychosomatics. 2017. PMID: 27889083 Free PMC article. No abstract available.
-
Clinical features of dementia with lewy bodies in 35 Chinese patients.Transl Neurodegener. 2014 Jan 8;3(1):1. doi: 10.1186/2047-9158-3-1. Transl Neurodegener. 2014. PMID: 24398160 Free PMC article.
References
-
- Kosaka K, Oyanagi S, Matsushita M, Hori A. Presenile dementia with Alzheimer-, Pick- and Lewy-body changes. Acta Neuropathol. 1976;36:221–233. - PubMed
-
- Kosaka K. Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol. 1978;42:127–134. - PubMed
-
- Rosenblum WI, Ghatak NR. Lewy bodies in the presence of Alzheimer's disease. Arch Neurol. 1979;36:170–171. - PubMed
-
- Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? Clin Neuropathol. 1984;3:185–192. - PubMed
-
- McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124. - PubMed
LinkOut - more resources
Full Text Sources